Early-stage VC Inflexor Ventures raises Rs 600-crore fund
SECTIONS
Share
Synopsis
SBICAP Ventures, SIDBI by way of its Fund of Funds come in as institutional limited partners in Inflexor Technology Fund, which also has a green shoe option of Rs 100 crore.
ETtech
Inflexor Ventures joins a bevy of rupee funds that have raised capital from domestic investors in the recent past. (Illustration: Rahul Awasthi/ETtech)
Mumbai: Early-stage tech-focused venture capital fund Inflexor Ventures has raised Rs 600 crore towards the final close of its new fund, driven by oversubscription from homegrown institutional investors.
The total fundraise has exceeded its initial target of Rs 500 crore and includes a green shoe option of Rs 100 crore, senior fund officials said.
Pune-based startup Ahammune Biosciences raises funds to develop vitiligo drug
Pune-based startup Ahammune Biosciences raises funds to develop vitiligo drug
26 April 2021 | News The fresh funds raised will be utilized for “first-in-human” studies with Ahammune’s new drug candidate AB1001 for vitiligo
Image credit- shutterstock.com
Pune-based biotech startup company, Ahammune Biosciences has raised an undisclosed amount in a Pre-Series A round led by Ideaspring Capital and Indian Angel Network. Kotak Private Equity, Legacy Assets LLP (Baldota family fund), and Dr. Ajith Kamath (ex-Pfizer) have also participated in the round along with existing investors, including Dr. Anand Deshpande and Suman Kant Munjal. The Company also has Dr. Ganesh Natarajan as an existing investor and has been in receipt of funding grant from Government of India’s body, BIRAC.
Ahammune Biosciences raises Pre-Series A funding from Ideaspring Capital, Indian Angel Network
April 26, 2021
, March 26
Pune-based biotech start-up company Ahammune Biosciences has raised an undisclosed amount in a Pre-Series A round led by Ideaspring Capital and Indian Angel Network.
Kotak Private Equity, Legacy Assets LLP (Baldota family fund) and Ajith Kamath (ex-Pfizer) have also participated in the round along with existing investors, including Anand Deshpande and Suman Kant Munjal. The Company also has Ganesh Natarajan as an existing investor and has been in receipt of funding grant from Government of India’s body, BIRAC.
The freshly-infused capital will be used for “first-in-human” studies with Ahammune’s new drug candidate AB1001 for vitiligo. The study will comprise Phase-I safety studies in healthy human volunteers and Phase-II efficacy studies in vitiligo patients. The company will also deploy the funds in building the patent portfolio to further the resear
Skyroot Teams Up With Bellatrix For Vikram Launcher Space Taxis Project
Share story
This partnership will help Skyroot to enhance its launch capabilities to meet specialised customer requirements
Last year, Skyroot successfully test-fired upper stage rocket engines, Kalam-5 and Raman
Hyderabad-based space tech startup Skyroot Aerospace and Bengaluru-based small satellite maker Bellatrix Aerospace have signed a partnership to share and cross-leverage each company’s technology platforms for space taxi launches by 2023.
The two spacetech startups will work together on an orbital transfer vehicle (OTV) by 2023 using ISRO’s Vikram launch vehicle. Skyroot’s upper stage rocket engine capabilities will be integrated with Bellatrix’s orbital transfer vehicles to transport satellites, cargo or supplies into space.
DeepTech Startup Atomberg Technologies secures Rs 70 crore funding led by A91 Partners Atomberg aiming to use funds raised to strengthen distribution networks and build brand awareness. TechSamvad December 10, 2020 10:44:25 IST Atomberg logo
Energy-efficient smart fans maker Atomberg Technologies has raised Rs 70 crore in Series B funding led by A91 Partners. The round also saw participation from Suman Kant Munjal s family office Survam Partners and Trifecta Capital. With this financing, the startup has raised a total Rs 160 crore till date. It was founded in 2012 by Sibabrata Das and Manoj Kumar Meena.
The Mumbai-based firm plans to use the funds raised to strengthen its distribution networks across all metro and non-metro cities, ramping up its production capacity, and for building brand awareness. The proceeds will also be used to expand its existing p